Details for New Drug Application (NDA): 083220
✉ Email this page to a colleague
The generic ingredient in OGEN 5 is estropipate. There are two drug master file entries for this compound. Additional details are available on the estropipate profile page.
Summary for 083220
Tradename: | OGEN 5 |
Applicant: | Pfizer |
Ingredient: | estropipate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.75MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1.5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 3MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Complete Access Available with Subscription